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Abstract
Aims/hypothesis Wewanted to identify a five-item short form
of the Problem Areas in Diabetes Scale and a single-item
measure for rapid screening of diabetes-related emotional
distress.
Methods Using an existing database of 1,153 patients with
diabetes, we conducted a principal-components analysis to
identify a set of five items and then conducted a reliability
analysis and validity checks. From those five items, we
identified the item with the strongest psychometric properties
as a one-item screening tool.
Results We identified a reliable and valid short version
of the Problem Areas in Diabetes Scale (PAID)
comprising five of the emotional-distress questions of
the full PAID items (PAID-5, with items 3, 6, 12, 16,
19). The PAID-5 has satisfactory sensitivity (94%) and
specificity (89%) for recognition of diabetes-related
emotional distress. We also identified a one-item
screening tool, the PAID-1 (Question 12: Worrying
about the future and the possibility of serious compli-
cations), which has concurrent sensitivity and specificity
of about 80% for the recognition of diabetes-related
emotional distress.
Conclusions/interpretation The PAID-5 and PAID-1 appear
to be psychometrically robust short-form measures of
diabetes-related emotional distress.
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The prevalence of serious psychological distress in people
with diabetes is significant and contributes to disease-
related burden [1]. Consequently, international guidelines
advocate routine screening for psychological problems
[2, 3]. The Problem Areas in Diabetes Scale (PAID) [4]
has been recommended for identifying depression and
diabetes-related distress [5]. The PAID is a widely used
measure, containing 20 items which have a five-point
response option (0–4 representing ‘Not a problem’ through
to ‘Serious problem’). The PAID has four factors or
dimensions measuring diabetes-related emotional problems
(12 questions), treatment-related problems (three ques-
tions), food-related problems (three questions), and social
support-related problems (two questions). The PAID has
been translated into various languages, is widely employed
to monitor change following an intervention and its
psychometric properties have been established [6, 7].
However, while clinically useful, wider use of the PAID
may be limited by its length.
Recently, a two-item screening version of the Diabetes
Distress Scale (DDS) was validated and showed good
sensitivity (95%) and specificity (85%) [8]. However, as
the PAID remains a more widely used instrument, we
aimed to develop a five-item short form for routine
clinical and research use and a single-item measure that
may be used as a rapid screen for diabetes-related
emotional distress.
Methods
Participants Our sample comprised 1,153 respondents to
the PAID from an ongoing international, multicentre study
of psychosocial care in diabetes (Diabetes Attitudes Wishes
and Needs [DAWN] Monitoring Individual Needs in
Diabetes [MIND] study) [9]. Data on well-being (WHO
Five Item Measure of Wellbeing [WHO-5]) and on various
demographic and biomedical variables are also included.
The average age of respondents was 53.8 years (SD=
14.7; range=18–89), 601 (52.1%) were women, and most
were employed full-time (36.8%, n=424) or retired (26.4%,
n=304). A majority: had type 2 diabetes (63.2%, n=729);
reported having diabetes for 11 years or longer (52.6%, n=
607); had no episodes of hypoglycaemia (78.1%, n=901);
and, in terms of treatment, were using insulin (49.6%, n=
572) or oral glucose-lowering agents (28.1%, n=324).
Finally, 54.9% (n=601) of participants reported no
diabetes-related complications, 24.7% (n=270) reported
having one complication, and 20.4% (n=223) reported
having two or more complications.
Procedure To identify a short-form version of the PAID,
two subsamples were randomly created (n=589 and n=564).
No statistically significant differences between the subsam-
ples were noted on the variables of age, sex composition,
type of diabetes, glycosylated haemoglobin level, work
status, complication frequency status and average WHO-5
scores. Thus, the random division produced comparable
groups of participants.
Results
Five-item short form For subgroup 1, we conducted a
principal-components analysis, which is an item-reduction
technique, and found a one-component solution. Ten items
loaded above 0.50, all of which were from the Diabetes-
related Negative Emotions subscale (items 3, 6, 7, 8, 9, 10,
12, 16, 19, 20). We removed three items rated on average
by respondents as less than a ‘minor problem’ (items 8, 10,
20) and the remaining seven items were subjected to a
reliability analysis. The two items which correlated most
poorly with the other items were removed, resulting in a
five-item short-form version (items 3, 6, 12, 16, 19—see
Electronic Supplementary Material [ESM]). Cronbach’s
alpha, a measure of the reliability or correlation between
items in a test, was good (see Table 1). Total scores on the
PAID-5 can range from 0 to 20, with higher scores
suggesting greater diabetes-related emotional distress. For
subsample 1, the average score was 6.07 (SD=5.09; range
0–20).
The PAID-5 total score correlated significantly with the
PAID-20 total score, r=0.92, p<0.001. The validity of the
PAID-5 was also demonstrated by a statistically significant
correlation with a measure of well-being (the WHO-5),
r=−0.47, p<0.001. The direction of this correlation
suggests that as diabetes-related distress increases, well-
being decreases. Correlations between the PAID-5 and the
other subscales of the PAID (treatment-related problems;
food-related problems; lack of social support) were also
investigated. Consistent with research suggesting that
different aspects of diabetes-related distress are interrelated,
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yet distinct, the PAID-5 correlated positively with scores
on the other problem areas: PAID-5/treatment, r=0.64;
PAID-5/food, r=0.61; PAID-5/social support, r=0.58 (all
p values <0.001). Finally, in accordance with previous
research on sex differences in diabetes-related distress [7],
we found that women had a significantly higher mean score
than men (women’s mean score=6.81, SD=5.27; men’s
mean score=5.23, SD=4.74) on the PAID-5, (t [587]=3.79,
p<0.001, Cohen’s d=0.32).
The five items retained from the analyses conducted with
subsample 1 were subjected to an exploratory factor
analysis (EFA) using subsample 2. In this context, the
EFA was used to identify the number of possible factors
reflected in the correlations among the five items. It was
anticipated that, as all items focused on diabetes-related
distress, a single factor would emerge. The data were not
normally distributed (i.e. scale items were positively
skewed). Thus, principal-axis factoring, a specific type of
EFA, was employed. A one-factor solution was found
(eigenvalue=2.97), accounting for approximately 59.3% of
the variance. Cronbach’s α was good (see Table 1), and the
mean score was 6.22 (SD=4.62, range=0-20).
As was observed with subsample 1, scores on the PAID-5
correlated negatively with scores on the WHO-5, r=−0.40,
p<0.001. Scores on the PAID-5 and problems related to
treatment, food, and social support also were found to
correlate significantly: PAID-5/treatment, r=0.60; PAID-5/
food, r=0.65; and PAID-5/social support, r=0.62 (all
p values <0.001). Again, female participants obtained
higher scores on the PAID-5 than male participants (women:
mean score=7.14, SD=4.93; men: mean score=5.27, SD=
4.06, t [546.10]=4.94, p<0.001, Cohen’s d=0.41).
Diagnostic accuracy of the PAID-5 was established
using receiver operating characteristic analysis with both
subsamples. To evaluate the ability of the PAID-5 to
‘diagnose’ high distress, a cut-off score of ≥33 on the 20
item PAID was used [5]. Using the optimal cut-off score of
≥8 on the PAID-5, the AUC value was 0.97 (95% CI 0.96–
0.98) in subsample 1 and 0.98 (95% CI 0.97–0.99) in
subsample 2, while sensitivity was 95% and specificity was
89% for each of the subsamples.
Single-item screening measure Based on its psychometric
properties, Item 12 (‘Worrying about the future and the
possibility of serious complications’), hereafter called
PAID-1, appeared most suitable as a rapid screen for
diabetes distress. For subsamples 1 and 2, scores on this
item correlated significantly with the WHO-5, the 20 item
PAID and with scores on the treatment, food, and social
support subscales of the PAID. The same sex difference
noted for the PAID-5 emerged, with women having
significantly higher scores on this item in each subsample.
When using a cut-off score of ≥33 on the 20 item PAID
(5), the optimal cut-off score of ≥3 on the PAID-1 yielded
AUC values of 0.87 (95% CI 0.84–0.90) and 0.86 (95%
CI 0.82–0.89) for subsamples 1 and 2. Sensitivity and
specificity values were (in order): 75% and 86% (subsam-
ple 1) and 74% and 86% (subsample 2).
Discussion
Our findings suggest that a five-item version of the PAID
possesses good reliability and validity. The diagnostic
accuracy of the scale was acceptable, achieving a sensitivity
rate of 95% and a specificity rate of 89%. The PAID-1
appears suitable for screening purposes in clinical settings,
with adequate validity and a diagnostic accuracy of around
80%. However, a high score on this item should prompt the
clinician to administer the longer (and more reliable) PAID-5
(see ESM).
A major strength of the PAID-5 is that it takes less than
1 min to complete, yet it has comparable ‘diagnostic’
performance to the four-item Diabetes Distress Scale [9].
Both contain items assessing fear, depressed mood and the
demands of living with diabetes; the PAID-1 focuses
uniquely on concerns for the future, and this item is also
included within the PAID-5.
Previous research has demonstrated that brief, verbally
administered questions are effective at identifying depres-
sion in primary care [10]. Future research might seek to
compare the effectiveness of verbal vs written administra-
Measure Cronbach’s α (95% CI)
Subsample 1 (n=589) Subsample 2 (n=564)
PAID-5 0.86 (0.84–0.88) 0.83 (0.80–0.85)
PAID-Treatment problems 0.67 (0.63–0.72) 0.66 (0.60–0.70)
PAID-Food problems 0.77 (0.73–0.80) 0.78 (0.75–0.81)
PAID-Lack of social support r=0.54a r=0.66a
WHO-5 0.84 (0.82–0.86) 0.85 (0.83–0.87)
Table 1 Scale score reliability
for all measures
a Two-item measure; thus, a
correlation coefficient was
computed (p<0.001)
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tion of the PAID-1, as well as its sensitivity to change
following an intervention.
Additional psychometric testing of the PAID-5 and
PAID-1 is required. However, the current study suggests
that clinicians may now choose from more than one short-
form measure of diabetes-related emotional distress, with
their choice of scale likely to depend on local practice and
previous experience.
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